Market Cap

4D pharma plc Market Capitalization:

£30.0 Million

GBP as of Nov. 1, 2022

US$34.2 Million

business 4D pharma plc Company Profile

4D pharma plc Main Stock Listing

LSE: DDDD

Market Capitalization History of 4D pharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of 4D pharma plc market cap

Date Market Cap YoY Change
Jan. 1, 2022 £67.6 M -67.67%
Jan. 1, 2021 £209.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

4D pharma plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

4D pharma plc has the following listings and related stock indices.


Stock: LSE: DDDD

Stock: XSTU: 4DY

Stock: FSX: 4DY

Stock: FSX: 4DY0

Stock: NASDAQ: LBPS

Stock: OTC: FRPRF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.